Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.
Author
Taylor, James M.
Dunkerley, Sarah
Silver, David A.
Redfern, Andrew
Talbot, Nick J.
Sharpe, Ian T.
Guyver, Paul M.
Date
2016-03Journal
Foot (Edinburgh, Scotland)Type
Journal ArticlePublisher
ElsevierDOI
10.1016/j.foot.2015.08.007Rights
Archived with thanks to Foot (Edinburgh, Scotland)Metadata
Show full item recordAbstract
Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT.